'Clin cancer res' diaporamas de présentation

1.1k views • 85 slides

Non-small Cell Lung Cancer

Non-small Cell Lung Cancer. Eva Szabo, MD Division of Cancer Prevention, NCI. TRACO 11-14-11. US Lung Cancer Statistics, 2010 227,890 estimated new cases. 158,070 estimated deaths leading cause of cancer deaths greater than breast+prostate+colon

1.59k views • 57 slides

Treatment in Advanced Non-Small Cell Lung Cancer

Treatment in Advanced Non-Small Cell Lung Cancer. NSCLC| Epidemiology- Australia. 5 th most commonly diagnosed cancer in Australia 8.9% of new cancer diagnoses In 2009: 10,193 cases ( 6034 men, 4159 women) Projection to 2020 ? 13,640 Mortality

785 views • 49 slides

EBV positive DLBCL of the elderly

760 views • 49 slides

819 views • 48 slides

I FARMACI MULTITARGETED NEL CANCRO DELLA MAMMELLA

605 views • 46 slides

Are we making any progress in the molecular taxonomy of CRC?

493 views • 41 slides

Cancer Immunotherapy: Fundamental Concepts and Emerging Role Oncology Perspective

811 views • 40 slides

Prescribing information can be found on the last slide

Study JMDB - A Randomised Phase III Trial of Cisplatin + Pemetrexed vs. Cisplatin + Gemcitabine in Locally Advanced or Metastatic Non-small Cell Lung Cancer ( Scagliotti et al , 2007). Prescribing information can be found on the last slide. IEALM00180 November 2012.

534 views • 33 slides

Network-centric Biomedicne : toward a learning healthcare system

Network-centric Biomedicne : toward a learning healthcare system. Ken Buetow , Ph.D. Director Computational Science and Informatics Core Program, Complex Adaptive Systems Initiative Arizona State University Biomedical Knowledge Cloud: A Network to Transform Healthcare

467 views • 32 slides

GASTROINTESTINAL STROMAL TUMORS (GIST) IN NEUROFIBROMATOSIS 1 (NF1) PATIENTS: A CLINICOPATHOLOGIC ANALYSIS OF NINE CAS

637 views • 26 slides

Microarray Identifies Best Cancer Type Markers

UK clinical trials Update 2019 CUP Harpreet S. Wasan Consultant / Reader in Medical oncology Department of Cancer Medicine Hammersmith Hospital, Imperial College London h.wasan @ imperial.ac.uk. Microarray Identifies Best Cancer Type Markers. 79 genes. qRT -PCR. c. FFPET. Colorectal.

187 views • 18 slides

Background (1)

247 views • 16 slides

352 views • 16 slides

http://proteomics.cancer.gov

http://proteomics.cancer.gov. Experimental Design and Biospecimens. David F. Ransohoff, MD Division of Gastroenterology and Hepatology; Dept. of Medicine Department of Epidemiology, School of Public Health Director, Clinical Research Curriculum (K30) Lineberger Comprehensive Cancer Center

265 views • 15 slides

Matthew L. Anderson, MD, PhD Department of Obstetrics & Gynecology & Dan L. Duncan Cancer Center

Small Molecule Inhibitors for Polo-Like Kinase 1 (Plk-1) Sensitize Uterine Leiomyosarcoma to Rapamycin. Matthew L. Anderson, MD, PhD Department of Obstetrics & Gynecology & Dan L. Duncan Cancer Center Baylor College of Medicine. Uterine Smooth Muscle Tumors. Leiomyomas (Fibroids)

323 views • 14 slides

BAP1 and involvement in Mesothelioma, CMML, Uveal (eye) melanoma

BAP1 and involvement in Mesothelioma, CMML, Uveal (eye) melanoma. BAP1 is a de- ubiquitinating enzyme (DUB) found in the nucleus. BAP1 has many roles within the cell. Developmental problems in mice. BAP1 mutations are found in many human cancers. Breast Lung Skin Kidney Prostate Ovary

607 views • 13 slides

SARC015: Phase II study of R1507 in wild-type GIST

SARC015: Phase II study of R1507 in wild-type GIST. Margaret von Mehren, Fox Chase Cancer Center Katie Janeway, Dana Farber Cancer Institute. 10% of GISTs in adults and 85% of GISTs in pediatric patients are wild-type (WT) TKIs in WT GIST TKIs in pediatric GIST

293 views • 12 slides

Comprehensive Case Study: Cancer Patient and Malnutrition

631 views • 10 slides